For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Research and development | 12,843 | 37,428 | ||
| General and administrative | 10,791 | 11,936 | ||
| Total operating expenses | 23,634 | 49,364 | ||
| Revenue | - | 41,095 | ||
| Loss from operations | -23,634 | -8,269 | ||
| Interest income | 833 | 1,381 | ||
| Other income (expense), net | 403 | -818 | ||
| Total other income, net | 1,236 | 563 | ||
| Loss before income tax expense | -22,398 | -7,706 | ||
| Income tax expense | - | 361 | ||
| Net loss | -22,398 | -8,067 | ||
| Unrealized loss on available-for-sale securities, net | -3 | -15 | ||
| Foreign currency translation (loss) gain | -415 | 656 | ||
| Total other comprehensive (loss) income, net | -418 | 641 | ||
| Comprehensive loss | -22,816 | -7,426 | ||
| Basic EPS | -0.39 | -0.23 | ||
| Diluted EPS | -0.39 | -0.23 | ||
| Basic Average Shares | 57,304,181 | 35,357,641 | ||
| Diluted Average Shares | 57,304,181 | 35,357,641 | ||
Equillium, Inc. (EQ)
Equillium, Inc. (EQ)